Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Other Non-Current Assets (2023 - 2026)

Camp4 Therapeutics (CAMP) posted Other Non-Current Assets of $1.6 million for Q1 2026, up 78.97% sequentially from $894000.0 in Q4 2025, and down 1.48% YoY from $1.6 million in Q1 2025.

Analysis

Camp4 Therapeutics (CAMP) Other Non-Current Assets (2023 - 2026) Analysis & Trends

Camp4 Therapeutics has reported Other Non-Current Assets for 4 years, with the latest figure at $1.6 million in Q1 2026.

  • Quarterly Other Non-Current Assets fell 1.48% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 1.48% YoY) and the FY2025 annual result came in at $894000.0, up 109.37% from the prior year.
  • Other Non-Current Assets improved to $1.6 million in Q1 2026 per CAMP's latest filing, from $894000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.6 million in Q3 2023 and troughed at $427000.0 in Q4 2024.
  • A 4-year average of $1.4 million and a median of $1.6 million in 2023 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets plunged 73.71% in 2024, then surged 109.37% in 2025.
  • Over 4 years, Other Non-Current Assets stood at $1.6 million in 2023, then slumped by 73.71% to $427000.0 in 2024, then soared by 109.37% to $894000.0 in 2025, then surged by 78.97% to $1.6 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.6 million, $894000.0, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - 1.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Mar 31, 2026 1.60 Mn
Dec 31, 2025 2.20 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 1.62 Mn
Dec 31, 2024 1.62 Mn
Sep 30, 2024 3.32 Mn
Dec 31, 2023 1.62 Mn
Sep 30, 2023 1.62 Mn